Actively Recruiting

Phase Not Applicable
Age: 18Years - 100Years
All Genders
NCT07153692

Clinical Efficacy and Mechanism of tDCS for Dysphagia in PD

Led by Wang Ping · Updated on 2025-09-04

58

Participants Needed

1

Research Sites

245 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to verify transcranial direct current stimulation(tDCS) efficacy for Parkinson's disease (PD)-related dysphagia and its mechanism. Subjects are randomly split into two groups: control (sham tDCS + conventional dysphagia treatment) and experimental (real tDCS + conventional treatment). Assessments will be conducted at baseline, after the completion of intervention, and at the 3-month follow-up. Swallowing function will be evaluated via gold-standard videofluoroscopic swallowing study (VFSS) and scales. Resting-state functional magnetic resonance imaging (rs-fMRI) or functional near-infrared spectroscopy (fNIRS) will be measures for tracking changes in abnormal brain regions/networks. Correlations between swallowing recovery and brain function changes, plus group imaging differences, will reveal tDCS's neurophysiological mechanism.

CONDITIONS

Official Title

Clinical Efficacy and Mechanism of tDCS for Dysphagia in PD

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Meet the Chinese Diagnostic Criteria for Parkinson's Disease (2016) or MDS Diagnostic Criteria for Multiple System Atrophy or Progressive Supranuclear Palsy
  • Dysphagia confirmed by videofluoroscopic swallowing study (VFSS)
  • Mini-Mental State Examination (MMSE) score greater than 23
  • Willing to cooperate with the study and sign informed consent
Not Eligible

You will not qualify if you...

  • Having other diseases that cause dysphagia
  • Having pneumonia or severe cardiac or renal insufficiency
  • Having metal implants in the body
  • Cognitive impairment or inability to cooperate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, China, 310000

Actively Recruiting

Loading map...

Research Team

P

Ping Wang, MS

CONTACT

B

Bo Wang, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here